When is surgery for metastatic melanoma still the most appropriate treatment option?

Erica B Friedman¹, Peter M Ferguson^{1

2

3}, John F Thompson^{1

4

3}

Affiliations

¹ a Melanoma Institute Australia , The University of Sydney , North Sydney , Australia.
² b Department of Tissue Pathology and Diagnostic Oncology , Royal Prince Alfred Hospital , Camperdown , Australia.
³ d The Faculty of Medicine and Health , The University of Sydney , Sydney , NSW , Australia.
⁴ c Department of Melanoma and Surgical Oncology , Royal Prince Alfred Hospital , Camperdown , NSW , Australia.

Editorial

Erica B Friedman et al. Expert Rev Anticancer Ther. 2018 Oct.

. 2018 Oct;18(10):943-945.

doi: 10.1080/14737140.2018.1508346. Epub 2018 Aug 9.

Erica B Friedman¹, Peter M Ferguson^{1

2

3}, John F Thompson^{1

4

3}

¹ a Melanoma Institute Australia , The University of Sydney , North Sydney , Australia.
² b Department of Tissue Pathology and Diagnostic Oncology , Royal Prince Alfred Hospital , Camperdown , Australia.
³ d The Faculty of Medicine and Health , The University of Sydney , Sydney , NSW , Australia.
⁴ c Department of Melanoma and Surgical Oncology , Royal Prince Alfred Hospital , Camperdown , NSW , Australia.

No abstract available

Keywords: Adjuvant therapy; melanoma; metastases; multidisciplinary care; surgery; systemic therapy.

Publication types